Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Heggie has lots of experience in the rare disease field, having served in senior roles at Shire, as a board member at Sobi and as CEO of German rare disease biotech

Shire’s angioedema drug Takhzyro recommended in Europe

Shire’s angioedema drug Takhzyro recommended in Europe The European Medicines Agency's CHMP committee has recommended Shire’s Takhzyro (lanadelumab), a new rare disease treatment which has blockbuster potential. ... Approved in the US in August, the drug is important for Shire, which is in the midst of a

Roche gets wider approval for haemophilia drug Hemlibra

Roche gets wider approval for haemophilia drug Hemlibra The broader indication means that Hemlibra can now challenge the entire range of factor VIII drugs in the marketplace – both short-acting and newer long-acting versions such as Shire’s

Finalists

by Shire. with support from CMC. Spotlight on Myeloma. by Takeda Oncology.

New Awards scheme for medical and scientific professionals

Demand for this new initiative has been strong – with entries / nominations from Novo Nordisk, BMS, Eisai, GSK, Shire, Gilead, Lundbeck, Bayer, Boehringer, Teva and more.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Infographics